OTCMKTS:ACURAcura Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Acura Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.32 -0.02 (-5.97 %) (As of 06/2/2020 04:00 PM ET) Add Compare Share Today's Range$0.31Now: $0.32▼$0.3550-Day Range$0.14MA: $0.31▼$0.4052-Week Range$0.12Now: $0.32▼$0.63Volume6,206 shsAverage Volume14,019 shsMarket Capitalization$6.82 millionP/E RatioN/ADividend YieldN/ABeta1.12 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Acura Pharmaceuticals. Previous Next 2.8 Community Rank Outperform VotesAcura Pharmaceuticals has received 197 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAcura Pharmaceuticals has received 156 “underperform” votes. (Add your “underperform” vote.)Community SentimentAcura Pharmaceuticals has received 55.81% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Acura Pharmaceuticals and other stocks. Vote “Outperform” if you believe ACUR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ACUR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAcura Pharmaceuticals does not currently pay a dividend.Dividend GrowthAcura Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Acura Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.60% of the stock of Acura Pharmaceuticals is held by insiders. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Acura Pharmaceuticals is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Acura Pharmaceuticals is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolOTCMKTS:ACUR Previous SymbolNASDAQ:ACUR CUSIP00509L70 CIK786947 Webwww.acurapharm.com Phone847-705-7709Debt Debt-to-Equity RatioN/A Current Ratio1.10 Quick Ratio1.10Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.66 million Price / Sales2.56 Cash FlowN/A Price / Cash FlowN/A Book Value($0.22) per share Price / Book-1.43Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-142.04% Return on EquityN/A Return on Assets-49.85%Miscellaneous Employees14 Outstanding Shares21,650,000Market Cap$6.82 million Next Earnings Date10/6/2020 (Estimated) OptionableNot Optionable OTC:ACUR Rates by TradingView Receive ACUR News and Ratings via Email Sign-up to receive the latest news and ratings for ACUR and its competitors with MarketBeat's FREE daily newsletter. Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions How has Acura Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)? Acura Pharmaceuticals' stock was trading at $0.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACUR stock has decreased by 7.4% and is now trading at $0.3150. View which stocks have been most impacted by Coronavirus. When is Acura Pharmaceuticals' next earnings date? Acura Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, October 6th 2020. View our earnings forecast for Acura Pharmaceuticals. How were Acura Pharmaceuticals' earnings last quarter? Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its quarterly earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company had revenue of $1.32 million for the quarter. View Acura Pharmaceuticals' earnings history. Has Acura Pharmaceuticals been receiving favorable news coverage? Press coverage about ACUR stock has trended extremely negative this week, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Acura Pharmaceuticals earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutAcura Pharmaceuticals. Who are some of Acura Pharmaceuticals' key competitors? Some companies that are related to Acura Pharmaceuticals include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Zoetis (ZTS), Allergan (AGN), Horizon Therapeutics (HZNP), Mylan (MYL), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX) and Corcept Therapeutics (CORT). View all competitors. What other stocks do shareholders of Acura Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acura Pharmaceuticals investors own include Denali Therapeutics (DNLI), Adamis Pharmaceuticals (ADMP), Ekso Bionics (EKSO), Corbus Pharmaceuticals (CRBP), Great Basin Scientific (GBSN), TrovaGene (TROV), Advanced Micro Devices (AMD), Ampliphi Biosciences (APHB), Arena Pharmaceuticals (ARNA) and Athersys (ATHX). Who are Acura Pharmaceuticals' key executives? Acura Pharmaceuticals' management team includes the following people: Mr. Robert B. Jones, CEO, Pres & Director (Age 60)Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 66)Mr. James F. Emigh, VP of Corp. Devel. (Age 63)Mr. Robert A. Seiser Ph.D., VP, Treasurer & Corp. Controller (Age 55) What is Acura Pharmaceuticals' stock symbol? Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR." How do I buy shares of Acura Pharmaceuticals? Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Acura Pharmaceuticals' stock price today? One share of ACUR stock can currently be purchased for approximately $0.32. How big of a company is Acura Pharmaceuticals? Acura Pharmaceuticals has a market capitalization of $6.82 million and generates $2.66 million in revenue each year. Acura Pharmaceuticals employs 14 workers across the globe. What is Acura Pharmaceuticals' official website? The official website for Acura Pharmaceuticals is www.acurapharm.com. How can I contact Acura Pharmaceuticals? Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at 847-705-7709 or via email at [email protected] This page was last updated on 6/3/2020 by MarketBeat.com Staff
